Anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs), such as cetuximab and panitumumab, have been widely used in the treatment of metastatic or advanced CRC [3, 4]. The gene discussed is EGFR; the disease is colorectal carcinoma.